Search Results for '100 hcv'

100 hcv published presentations and documents on DocSlides.

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

by briana-ranney

Sofosbuvir + Ribavirin to Prevent Post-Transplan...

Treatment of Hepatitis C in patients with

Treatment of Hepatitis C in patients with

by tatyana-admore

thalassaemia. . Where . are we now?. Telaprevir ....

C-EDGE Co-Infected: Phase 3 Study of

C-EDGE Co-Infected: Phase 3 Study of

by giovanna-bartolotta

C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...

Performance evaluation of the Hologic

Performance evaluation of the Hologic

by ariel

Aptima. HCV Quant . Dx. assay for detection of H...

by celsa-spraggs

Morris Sherman MD . BCh. PhD FRCP(C) . Associate...

by giovanna-bartolotta

OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...

by faustina-dinatale

Design. Open-label. CURRY . Study. : SOF + RBV fo...

by pasty-toler

OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...

www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com

www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com

by luanne-stotts

. HCV Training Workshop. Version 19.0. HCSP/HCV ...

Breakout session Ryan White

Breakout session Ryan White

by lydia

Marion Peters. August 2020. ARS Question 1:. Which...

SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1

SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1

by test

SURVEYOR-I: 98% – 100% SVR4 in HCV Genotype 1 No...

CONSUMER FINANCIAL PROTECTION BUREAU

CONSUMER FINANCIAL PROTECTION BUREAU

by eddey

CFPB Bulletin 2015DATEMay 11 2015SUBJECT15 USC 16...

NS5A and polymerase inhibitors

NS5A and polymerase inhibitors

by LoveBug

Mark Sulkowski, MD. Professor of Medicine. Johns H...

Are (exogenous) interferons

Are (exogenous) interferons

by amey

really necessary?. Peter . Ferenci. Medical Univer...

State of the Art Therapy for HCV

State of the Art Therapy for HCV

by liane-varnes

Last Updated: February . 21, 2014. Robert G. Gish...

by pasty-toler

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

by tawny-fly

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

by lois-ondreau

400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...

by tawny-fly

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

Ledipasvir-Sofosbuvir in GT-1

Ledipasvir-Sofosbuvir in GT-1

by faustina-dinatale

. and HIV Coinfection. NIAID ERADICATE Trial. Ph...

by briana-ranney

Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...

by stefany-barnette

Randomisation*. Open-label. >. 18 years. HCV ...

≥ 18 years, HCV genotype 1-6

≥ 18 years, HCV genotype 1-6

by karlyn-bohler

≥ 18 years, HCV genotype 1-6 HCV RNA > 1 00...

Webinar presented by : ANDES

Webinar presented by : ANDES

by teresa

Prediction. . of . events. . after. ART. initia...

Special session #10: GRADE: the past 15 and next … years

Special session #10: GRADE: the past 15 and next … years

by felicity

for prognostic evidence . Alfonso Iorio, . MD, PhD...

EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF

EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF

by hezekiah

FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...